AB
TVTX icon

Amalgamated Bank’s Travere Therapeutics TVTX Stock Holding History

Amalgamated Bank’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,592
Closed -$99K – 2741
2025
Q4 		$99K Sell
2,592
-308
-11% -$10K ﹤0.01% 1702
2025
Q3 		$69K Hold
2,900
– – ﹤0.01% 1758
2025
Q2 		$43K Hold
2,900
– – ﹤0.01% 1861
2025
Q1 		$52K Buy
2,900
+343
+13% +$6.96K ﹤0.01% 1791
2024
Q4 		$45K Hold
2,557
– – ﹤0.01% 1862
2024
Q3 		$36K Hold
2,557
– – ﹤0.01% 1945
2024
Q2 		$21K Buy
2,557
+424
+20% +$2.86K ﹤0.01% 2103
2024
Q1 		$16K Sell
2,133
-7,615
-78% -$64.2K ﹤0.01% 2239
2023
Q4 		$88K Sell
9,748
-635
-6% -$4.62K ﹤0.01% 2045
2023
Q3 		$93K Hold
10,383
– – ﹤0.01% 2029
2023
Q2 		$159K Buy
10,383
+2,004
+24% +$36.5K ﹤0.01% 1911
2023
Q1 		$188K Sell
8,379
-1,232
-13% -$26.2K ﹤0.01% 1827
2022
Q4 		$202K Hold
9,611
– – ﹤0.01% 1862
2022
Q3 		$237K Buy
9,611
+141
+1% +$3.64K ﹤0.01% 1790
2022
Q2 		$229K Buy
9,470
+2,177
+30% +$54.8K ﹤0.01% 1820
2022
Q1 		$188K Sell
7,293
-504
-6% -$13.4K ﹤0.01% 1966
2021
Q4 		$242K Buy
+7,797
New +$220K ﹤0.01% 1903
2021
Q1 		– Sell
-7,649
Closed -$208K – 1623
2020
Q4 		$208K Buy
+7,649
New +$179K 0.01% 1433

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Amalgamated Bank's TVTX Position: Q1 2026 in Review

Amalgamated Bank sold out of Travere Therapeutics (TVTX) in Q1 2026, closing a stake of 2,592 shares — an estimated $99K sold.

Amalgamated Bank first reported a position in TVTX in Q4 2020 and held it in 18 quarters. The position peaked at $242K in Q4 2021. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Amalgamated Bank reported no remaining Travere Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 2,592 Travere Therapeutics shares in Q1 2026, an estimated $99K.
  • Amalgamated Bank first reported a position in Travere Therapeutics in Q4 2020 and held it in 18 quarters.
  • Amalgamated Bank's Travere Therapeutics position peaked at $242K in Q4 2021.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.